Industrial technology company Fortive (NYSE: FTV) beat Wall Street’s revenue expectations in Q3 2026, with sales up 7.8% year on year to $1.11 billion. Its non-GAAP profit of $0.77 per share was 9.4% above analysts’ consensus estimates.

Is now the time to buy FTV? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Fortive’s third quarter results reflected continued momentum, with the company surpassing Wall Street’s revenue and non-GAAP earnings expectations and the stock reacting positively. Management attributed the outperformance to accelerating organic growth, particularly in its Intelligent Operating Solutions segment, and strong volume growth across professional instrumentation and facility software. CEO Olumide Soroye highlighted new product introductions at Fluke and ServiceChannel’s AI-enabled workflow tools as key contributors. He also pointed to robust demand in North America, an improving healthcare environment, and increasing recurring revenue from software and SaaS offerings as important drivers of performance.

Looking ahead, management raised Fortive’s full-year non-GAAP earnings outlook, citing confidence in their Accelerated Strategy. They emphasized continued investment in innovation and commercial capacity, especially for high-growth areas like data centers and healthcare software. CFO Mark Okerstrom noted that price realization and operational discipline are expected to support margin expansion, even as the company invests in new products and customer engagement. Management believes that the combination of recurring revenue, targeted M&A, and disciplined cost control will help sustain multi-year growth.

Key insights from management’s remarks

Management linked the quarter’s above-consensus results to product innovation, recurring revenue growth, and increased commercial capacity, while also noting ongoing investment in strategic priorities.

• Product innovation momentum: Fluke expanded its product lineup with new thermal and acoustic imagers, targeting early-career technicians and driving broader market reach. Industrial Scientific launched iNet Insights, enhancing gas detection platform capabilities and supporting the company’s recurring revenue model.

• AI-enhanced software adoption: ServiceChannel’s R2 release introduced AI-powered features for asset recognition and intelligent work order management, which improved customer workflows and contributed to growth in Facilities and Asset Lifecycle Solutions.

• Recurring revenue strength: The company reported ongoing gains in recurring revenue, particularly from SaaS platforms like eMaint and Provation. Management highlighted that recurring and non-recurring revenue both grew, but recurring streams support long-term durability and customer retention.

• Geographic and end-market breadth: All major regions contributed to growth, with North America continuing as the leading region. The IOS segment saw strength in data centers, defense, and education, supported by targeted commercial investment.

• Margin expansion and cost discipline: Adjusted EBITDA margin rose due to operating leverage and structural cost savings, partially offset by growth investments. Gross margin discipline was maintained despite inflation and changing product mix, with price increases and procurement countermeasures offsetting cost pressures.

Drivers of future performance

Management expects sustained organic growth driven by ongoing innovation, expansion in high-growth verticals, and margin improvement supported by operational discipline.

• Data center and software expansion: Investments in data center-specific products and dedicated sales teams are expected to unlock larger addressable markets, while AI-enabled software platforms in both industrial and healthcare segments should continue driving recurring revenue growth.

• Margin resilience amid cost pressures: Management anticipates maintaining strong gross margins through price discipline, value engineering, and supply chain management, even as inflationary pressures persist. Discrete investments and mix shifts may impact margins quarter to quarter, but the company targets annual adjusted EBITDA margin expansion in the 50-100 basis point range.

• Healthcare market recovery: While the U.S. hospital capital environment remains cautious, procedure volumes are stable to improving, and emerging markets show robust demand for healthcare consumables. Management sees ambulatory surgery centers as a key growth area, with targeted innovation and partnerships aiming to expand the installed base and customer adoption.

Catalysts in upcoming quarters

In the coming quarters, the StockStory team will be watching (1) the pace of adoption and incremental revenue from AI-enabled software products across both industrial and healthcare segments, (2) execution in expanding the data center and recurring revenue business lines, and (3) signs of margin resilience amid cost and mix headwinds. Additional attention will be given to targeted M&A activity and the ramp-up of new product introductions as key milestones for Fortive’s multi-year strategy.

Fortive currently trades at $64.13, up from $61.62 just before the earnings. Is there an opportunity in the stock? Find out in our full research report (it’s free).

Now could be the perfect time to invest in these stocks

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.